Is Cannabis Legal in the Netherlands?

The Tolerance Policy: How It Works

The Dutch gedoogbeleid is one of the most studied and most misunderstood drug policy frameworks in the world. Cannabis has not been legalised in the Netherlands. Under the Opium Act (Opiumwet) of 1928, as substantially amended in 1976, cannabis is a Schedule II controlled substance — categorised as presenting an "unacceptable risk" but less severe than Schedule I drugs such as heroin and cocaine. Possession and trade remain offences in law.

What the tolerance policy does is instruct prosecutors not to pursue charges for personal-quantity possession or for sales at licensed coffeeshops that operate within defined parameters. These parameters, known as the AHOJ-G criteria, require coffeeshops to avoid: advertising (Affichering), hard drugs (Harddrugs), nuisance to neighbours (Overlast), sales to minors under 18 (Jongeren), and stock exceeding 500 grammes (Grote hoeveelheden). Compliance with these criteria earns a licence from the local municipality; breach results in closure.

The Netherlands government's official cannabis policy page describes the system as designed to separate the cannabis market from harder drugs and reduce harm — a harm-reduction objective that has shaped Dutch public health discourse for half a century.

The Front-Door/Back-Door Problem

The structural incoherence at the heart of Dutch cannabis policy has a name: the "front-door/back-door problem" (voordeurbeleid/achterdeurbeleid). A licensed coffeeshop may legally sell cannabis to adults through its front door, but it may not legally obtain that cannabis through any regulated route. Supply — through the back door — is a criminal act for which cultivators can and do face prosecution.

This contradiction has practical consequences. Without a licit supply chain, coffeeshop operators must source cannabis from criminal networks, undermining the policy's public health rationale. Product quality and safety are unverified. Tax authorities cannot collect revenue from production. Cultivators operate under constant enforcement risk. The Wiet Experiment was conceived precisely to test whether a regulated supply chain could resolve this fundamental tension without triggering the political complications of outright legalisation.

The Coffeeshop System

Approximately 570 coffeeshops operate across the Netherlands as of 2026, down significantly from a peak of around 1,500 in the early 1990s. The decline reflects a policy of non-renewal and active reduction in the number of licences, particularly in border cities and in municipalities that have opted to prohibit coffeeshops entirely. Amsterdam accounts for roughly 150 to 160 establishments; Rotterdam, The Hague, Utrecht, and Eindhoven each host further concentrations.

Each coffeeshop licence is issued by the local municipality, which sets additional conditions beyond the national AHOJ-G framework. Some municipalities — particularly those in border regions — have adopted the "I-criterion" (ingezetenencriterium), requiring customers to demonstrate Dutch residency, a measure introduced to reduce "cannabis tourism" from neighbouring Belgium, Germany, and France. Amsterdam has historically resisted the residency requirement, though political pressure to adopt it has intensified.

Permitted Stock and Purchase Limits

Coffeeshops may hold a maximum of 500 grammes of cannabis stock on their premises at any one time — a limit that creates significant operational challenges for high-volume establishments. Customers may purchase up to 5 grammes per transaction. Multiple purchases on the same day are not tracked by any national system, though operators are expected to apply reasonable judgement. Prices, product range, and quality vary significantly between operators; the absence of a regulated supply chain means the category lacks the standardisation that consumers in licensed adult-use markets typically encounter.

The Wiet Experiment

The Experiment gesloten coffeeshopketen — commonly referred to as the Wiet Experiment or Weed Experiment — is the most significant development in Dutch cannabis policy in decades. The experiment was formally enacted under the Temporary Experimental Closed Cannabis Supply Chain Act (Wet experiment gesloten coffeeshopketen) and launched its operational phase in late 2023 after years of political delays and legal challenges.

Ten cities participate: Breda and Tilburg were among the first to receive licensed cultivators, with eight further municipalities subsequently integrated into the trial. In participating cities, coffeeshops are required to source cannabis exclusively from licensed private growers who operate under strict government specifications covering cultivation method, product safety testing, packaging, and labelling. The supply chain is "closed" — meaning experimental participants cannot purchase from the illicit market alongside licensed sources.

Licensed Cultivators

The government selected a cohort of private cultivators through a competitive tendering process. Licensed growers operate under conditions that closely resemble pharmaceutical-grade production: mandatory Good Agricultural and Collection Practice (GACP) standards, regular laboratory testing for pesticides, heavy metals, and microbiological contaminants, and strict chain-of-custody documentation. The intent is to demonstrate that commercially viable cannabis can be produced in the Netherlands under a quality-assured framework comparable to those in regulated international markets.

For European cannabis industry operators, the Wiet Experiment represents a reference model of considerable significance. The cultivator licensing process, quality standards, and retail integration approach may inform not only a future Dutch framework but also reform processes in other member states. The experiment is subject to independent scientific evaluation, with interim findings published by the research consortium overseeing the programme.

Medical Cannabis in the Netherlands

The Netherlands operates one of Europe's longest-established medical cannabis programmes. The Bureau voor Medicinale Cannabis (BMC), operating under the Ministry of Health, Welfare and Sport, has been the state authority responsible for regulating medicinal cannabis since 2003. The BMC sources cannabis both from domestic cultivation (carried out by contracted private growers under strict government specification) and from international imports, and it supplies this cannabis to pharmacies for dispensing against prescriptions.

Dutch medical cannabis is available in several standardised cultivar-based varieties, typically distinguished by their approximate THC and CBD content. Products are dispensed as dried flower for vaporisation or as oil. The prescribing base in the Netherlands is broader than in many European jurisdictions — general practitioners may prescribe medicinal cannabis, not only specialists — though the use of cannabis as a first-line therapy is not standard clinical practice.

Reimbursement through the public health insurance system (basisverzekering) is not standard; most patients bear the cost of medicinal cannabis prescriptions themselves. The cost differential between pharmacy-dispensed medical cannabis and coffeeshop cannabis has historically been a disincentive for patients to enter the formal medical route, a situation that the Wiet Experiment's quality standardisation is partly designed to address over time by raising quality benchmarks in the consumer market.

Business Opportunities and Licensing

The Netherlands offers a paradoxical commercial environment. It has the most established consumer cannabis market in Europe — decades of operational coffeeshop experience, deep consumer familiarity, and significant ancillary industry infrastructure — yet formal commercial licensing for adult-use production has not existed until the Wiet Experiment created a limited and temporary framework.

Businesses seeking to participate in the Dutch market in 2026 face several distinct pathways. The Wiet Experiment cultivator licences represent a direct route to legal cannabis production, though the cohort of licensed growers was selected in earlier tender rounds and the experiment operates on a closed basis. Medical cannabis supply is a second avenue: operators who achieve BMC accreditation or supply agreement status can access the pharmacy channel, which is regulated, quality-assured, and immune from the enforcement uncertainty that shadows the coffeeshop supply chain.

Ancillary services — cultivation technology, legal and regulatory advice, testing and analytics, retail operations consultancy — represent lower-regulatory-risk entry points for international businesses seeking Dutch market presence. Several European cannabis businesses with origins in the Netherlands have built export-oriented models that use the country's logistics infrastructure, port access, and financial services ecosystem to serve regulated markets across the continent.

The trajectory of the Wiet Experiment will be a defining variable for investment decisions through 2026 and 2027. A positive evaluation that leads to a proposal for permanent regulated supply would transform the Netherlands from a curiosity of drug policy history into a fully functioning commercial cannabis jurisdiction — and potentially one of the most attractive in Europe, given its infrastructure, liberalism, and central European position.

Penalties and Enforcement

Despite the tolerance policy, Dutch law retains a full penalty framework for cannabis offences. Possession above the 5-gramme threshold — or possession in circumstances that suggest supply — remains a prosecutable offence under the Opium Act. Large-scale cultivation and trafficking carry custodial sentences. The distinction between personal use and supply is determined by prosecutorial discretion and the circumstances of arrest.

Coffeeshop operators who breach the AHOJ-G criteria face administrative closure, fine, or criminal prosecution depending on severity. Local municipalities are responsible for licence monitoring and enforcement; the consistency of this oversight varies considerably between cities. Amsterdam's enforcement approach differs from that of smaller municipalities where political attitudes towards cannabis are more conservative.

For cannabis cultivators operating outside the Wiet Experiment framework, the enforcement environment has not materially softened. Police continue to dismantle illegal grow operations, which range from small residential sites to sophisticated industrial-scale facilities. The gap between the tolerant front door and the still-criminal back door is enforced, not merely theoretical.

2026 Outlook

The Netherlands stands at a genuinely pivotal moment in its cannabis policy history. The Wiet Experiment is generating the evidence base that Dutch politicians, for decades, argued was necessary before any fundamental change to the coffeeshop supply model. The quality of that evidence — and the political alignment of the government that receives it — will determine whether the Netherlands takes the next logical step towards formal regulated production and supply.

The current governing coalition, formed following the 2023 elections, includes parties with mixed views on cannabis reform. PVV and its coalition partners have been less enthusiastic about progressive drug policy than preceding governments. However, the experiment was legislated by an earlier parliament and operates on a multi-year timeline that insulates it from immediate political reversal. The scientific evaluation consortium is independent and its findings will carry public credibility regardless of the political climate at publication.

For European cannabis industry observers, the Netherlands illustrates a broader truth about the pace of reform: tolerance is not legalisation, and pragmatism is not policy. The country that effectively invented the consumer cannabis market has spent five decades unable — or unwilling — to complete the logical step of regulating its supply. Whether 2026 and 2027 mark the beginning of that resolution, or simply another chapter in a uniquely Dutch experiment in political equivocation, will have implications well beyond the Netherlands' borders.

The wider context for Dutch reform sits within a rapidly evolving European landscape, explored in our analysis of cannabis legalisation across Europe and our forward-looking assessment of where investment capital is flowing in 2026.